Related Experiment Video
Updated: May 16, 2026

11:44
Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis
Published on: March 30, 2019
miRNAs as modulators of angiogenesis
Shira Landskroner-Eiger1, Isabelle Moneke, William C Sessa
1Department of Pharmacology and Vascular Biology and Therapeutics Program, Yale University School of Medicine, New Haven, Connecticut 06519, USA.
Cold Spring Harbor Perspectives in Medicine
|November 22, 2012
Summary
MicroRNAs (miRNAs) are short noncoding RNAs that regulate gene expression. This study reviews their role in vascular development and angiogenesis, highlighting therapeutic potential.
Area of Science:
- Molecular Biology
- Genetics
- Biochemistry
Background:
- MicroRNAs (miRNAs) are short, conserved noncoding RNAs regulating gene expression post-transcriptionally.
- They are processed by Drosha and Dicer enzymes from RNA templates.
- miRNAs modulate diverse cellular processes including development, differentiation, and apoptosis.
Purpose of the Study:
- To review the current understanding of microRNA function in endothelial cells.
- To explore the role of miRNAs in vascular development and angiogenesis.
- To identify potential therapeutic applications of miRNAs in vascular biology.
Main Methods:
- Literature review of recent studies on microRNAs in vascular biology.
- Analysis of bioinformatics predictions regarding miRNA targets.
- Synthesis of current knowledge on miRNA biogenesis and function.
Main Results:
- MicroRNAs are highly expressed in endothelial cells and play a crucial role in angiogenesis.
- Over 1000 mammalian miRNAs have been identified, with predictions suggesting regulation of ~30% of protein-coding genes.
- miRNAs fine-tune cellular phenotypes rather than acting as simple on-off switches.
Conclusions:
- MicroRNAs are key regulators of vascular development and angiogenesis.
- Understanding miRNA mechanisms offers significant therapeutic opportunities for vascular diseases.
- Further research into miRNA-based therapies is warranted.
Related Concept Videos
Regulation of Angiogenesis and Blood Supply
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
MicroRNAs
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
MicroRNAs
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
MicroRNAs
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
Mechanism of Angiogenesis
Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
